CN109846842A - A kind of pet composite tablet and preparation method thereof - Google Patents
A kind of pet composite tablet and preparation method thereof Download PDFInfo
- Publication number
- CN109846842A CN109846842A CN201910095782.4A CN201910095782A CN109846842A CN 109846842 A CN109846842 A CN 109846842A CN 201910095782 A CN201910095782 A CN 201910095782A CN 109846842 A CN109846842 A CN 109846842A
- Authority
- CN
- China
- Prior art keywords
- parts
- composite tablet
- starch
- pet
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention provides a kind of pet composite tablets and preparation method thereof, the composite tablet is made of following components in parts by mass: 18 parts~22 parts of Pyrantel Pamoate, 8 parts~13 parts of praziquantel, 40 parts~50 parts of powdered beef, 15 parts~25 parts of starch, 1 part~10 parts of starch slurry, 1 part~2 parts of dextrin, 0.5 part~1 part of magnesium stearate.The preparation method comprises the following steps: in parts by mass, 18 parts~22 parts of Pyrantel Pamoate, 8 parts~13 parts of praziquantel, 40 parts~50 parts of powdered beef, 15 parts~25 parts of starch being mixed, softwood is obtained；0.5 part~1 part of magnesium stearate and 1 part~2 parts dextrin is added in granulation, whole grain, mixes, and tabletting obtains composite tablet.Preparation method simple process and low cost of the invention can be adapted for heavy industrialization generation, and the composite tablet smooth appearance being prepared is disintegrated rapidly after taking, and anthelminthic effect is good.
Description
Technical field
The present invention relates to pet medication preparation technical fields, more particularly, be related to a kind of pet composite tablet and its
Preparation method.
Background technique
With the continuous improvement of people's living standards, Medical pet technology is grown rapidly, the people for raising pet becomes
It is more and more, but the probability that pet is fallen ill is still larger, especially for the parasitic infection of pet.Currently, the country is for pet
The medication of helminth is infected there are slow effect, the problems such as anthelminthic effect is poor, and pharmaceutical preparation is complicated.
Summary of the invention
It is above-mentioned existing in the prior art it is an object of the present invention to solving for the deficiencies in the prior art
One or more problems.For example, that one of the objects of the present invention is to provide a kind of anthelminthic effects is good, quick, preparation process is simple
Single, pet composite tablet at low cost.
To achieve the goals above, an aspect of of the present present invention provides a kind of pet composite tablet, the composite tablet
It can be made of following components in parts by mass: 18 parts~22 parts of Pyrantel Pamoate, 8 parts~13 parts of praziquantel, beef
40 parts~50 parts of powder, 15 parts~25 parts of starch, 1 part~10 parts of starch slurry, 1 part~2 parts of dextrin, 0.5 part~1 part of magnesium stearate.
In an exemplary embodiment of pet composite tablet of the invention, the starch slurry can be mass fraction
6%~10% starch slurry.
In an exemplary embodiment of pet composite tablet of the invention, the composite tablet can be by pressing below
Mass parts meter at being grouped as: 19 parts~20 parts of Pyrantel Pamoate, 9 parts~11 parts of praziquantel, powdered beef 40 parts~50
Part, 15 parts~25 parts of starch, 1 part~10 parts of starch slurry, 1 part~2 parts of dextrin, 0.5 part~1 part of magnesium stearate.
In an exemplary embodiment of pet composite tablet of the invention, the composite tablet can be by pressing below
Mass parts meter at being grouped as: 20 parts of Pyrantel Pamoate, 10 parts of praziquantel, 40 parts~50 parts of powdered beef, 15 parts of starch~
25 parts, 1 part~10 parts of starch slurry, 1 part~2 parts of dextrin, 0.5 part~1 part of magnesium stearate.
In an exemplary embodiment of pet composite tablet of the invention, the usage and dosage of the composite tablet can
0.5 gram~1.0 grams of pet dosage for thinking every 5 kilograms~10 kg body weight.
Another aspect provides a kind of pet composite tablet preparation method, the preparation method may include
Following steps: in parts by mass, by 18 parts~22 parts of Pyrantel Pamoate, 8 parts~13 parts of praziquantel, 40 parts~50
The powdered beef of part, 15 parts~25 parts of starch mix, and obtain mixture；1 part~10 parts starch slurries, preparation are added in the mixture
Obtain softwood；0.5 part~1 part of magnesium stearate and 1 part~2 parts dextrin is added in granulation, whole grain, mixes, and tabletting obtains compound
Tablet.
In an exemplary embodiment of pet of the invention composite tablet preparation method, the starch slurry can be
The starch slurry of mass fraction 6%~10%.
In the exemplary embodiment of pet of the invention composite tablet preparation method, the mixture that obtains
Step may include in parts by mass, by 19 parts~20 parts of Pyrantel Pamoate, 9 parts~11 parts of praziquantel, 40 parts~
50 parts of powdered beef, 15 parts~25 parts of starch are uniformly mixed so as to obtain mixture.
In the exemplary embodiment of pet of the invention composite tablet preparation method, the mixture that obtains
Step may include in parts by mass, by 20 parts of Pyrantel Pamoate, 10 parts of praziquantel, 40 parts~50 parts of beef
Powder, 15 parts~25 parts of starch are uniformly mixed so as to obtain mixture.
Compared with prior art, preparation method simple process and low cost of the invention, can be adapted for heavy industrialization
Generation, the composite tablet smooth appearance being prepared are disintegrated rapidly after taking, and anthelminthic effect is good.
Detailed description of the invention
By the description carried out with reference to the accompanying drawing, above and other purpose of the invention and feature will become more clear
Chu, in which:
Fig. 1 shows the pet composite tablet preparation method flow diagram of an illustrative embodiment of the invention.
Specific embodiment
Hereinafter, pet composite tablet according to the present invention will be described in detail in conjunction with attached drawing and exemplary embodiment
And preparation method thereof.
Fig. 1 shows the pet composite tablet preparation method flow diagram of an illustrative embodiment of the invention.
An aspect of of the present present invention provides a kind of pet composite tablet, in an exemplary embodiment of the present invention,
The composite tablet can be composed of the following components, according to the mass fraction, 18 parts~22 parts of Pyrantel Pamoate, praziquantel 8
Part~13 parts, 40 parts~50 parts of powdered beef, 15 parts~25 parts of starch, 1 part~10 parts of starch slurry, 1 part of dextrin~2 parts, stearic acid
0.5 part~1 part of magnesium.
In the present embodiment, the starch slurry can be the starch slurry of mass fraction 6%~10%.Further, described
Starch slurry can be the starch slurry of mass fraction 10%.
In the present embodiment, further, the composite tablet can be made of following components in parts by mass: double hydroxyls
19 parts~20 parts of naphthoic acid Pyrantel, 9 parts~11 parts of praziquantel, 40 parts~50 parts of powdered beef, 15 parts~25 parts of starch, starch slurry 1
Part~10 parts, 1 part~2 parts of dextrin, 0.5 part~1 part of magnesium stearate.
In the present embodiment, further, the composite tablet can be made of following components in parts by mass: double hydroxyls
20 parts of naphthoic acid Pyrantel, 10 parts of praziquantel, 40 parts~50 parts of powdered beef, 15 parts~25 parts of starch, 1 part~10 parts of starch slurry, paste
1 part~2 parts, 0.5 part~1 part of magnesium stearate of essence.
In the present embodiment, the usage of the composite tablet can be doted on to be every 5 kilograms~10 kilograms to weight
The composite tablet of the invention that 0.5 gram~1.0 grams of object dosage.Certainly, composite tablet of the invention can equally follow the doctor's advice and take.
Another aspect provides a kind of pet composite tablet preparation methods, in pet compound of the invention
In one exemplary embodiment of method for preparing tablet thereof, as shown in Figure 1, the preparation method may include:
Step S01, in parts by mass, by 18 parts~22 parts of Pyrantel Pamoate, 8 parts~13 parts of praziquantel, 40
Part~50 parts of powdered beef, 15 parts~25 parts of starch uniformly mix, and mixture is prepared.
It in the present embodiment, further, in parts by mass, can be by 19 parts~20 parts of Pyrantel Pamoate, 9 parts
~11 parts of praziquantel, 40 parts~50 parts of powdered beef, 15 parts~25 parts of starch are uniformly mixed so as to obtain mixture.Further,
In parts by mass, can by 20 parts of Pyrantel Pamoate, 10 parts of praziquantel, 40 parts~50 parts of powdered beef, 15 parts~
25 parts of starch is uniformly mixed so as to obtain mixture.
Step S02 is added 1 part~10 parts of starch slurry, softwood is prepared.
In the present embodiment, 1 part~10 parts of starch slurry can be added in the mixture, softwood is prepared.
Further, 2 parts~8 parts of starch slurry can be added in the mixture, softwood is prepared.The starch slurry can be with
For the starch slurry of mass fraction 6%~10%.Further, the starch slurry can be the starch slurry of mass fraction 10%.
0.5 part~1 part of magnesium stearate and 1 part~2 parts dextrin is added in step S03, granulation, whole grain, mixes, and tabletting obtains
To composite tablet.
In the present embodiment, marumerization can be used softwood is pelletized, obtains carrying out again after dry particl whole
Grain.
In conclusion preparation method simple process of the invention, the composite tablet being prepared can be used in driving away pet
Intracorporal roundworm (such as: Toxocara canis, Toxocara cati, weight loss method), hookworm (such as ancylostoma caninum, ancylostoma braziliense,
Ancylostoma ceylonicum, narrow first curved mouth nematode), whipworm (such as: Trichuris vulpis), tapeworm (such as: band-like band tapeworm, Taenia Pisiformis,
Continuous multiceps, Mesocestoides fluke, carefully digs echinococcus, dibothriocephalus latus, winding palace category tapeworm at diphlidium caninum),
Fluke (Schistosoma japonicum, Schistosoma mansoni, clonorchis sinensis, Paragonismus westermani, paragonimus skriabini, Echinochasmus japonicus,
TaiWan, China spine band fluke, distoma conjunctum, Opisthorchis felineus, Fasciola hepatica), nematode etc. has anthelminthic effect good, takes effect
The advantages that fast.
Although those skilled in the art should be clear above by combining exemplary embodiment to describe the present invention
Chu can carry out exemplary embodiment of the present invention each without departing from the spirit and scope defined by the claims
Kind modifications and changes.
Claims (9)
1. a kind of pet composite tablet, which is characterized in that the composite tablet is made of following components in parts by mass: double
18 parts~22 parts of hydroxyl naphthoic acid Pyrantel, 8 parts~13 parts of praziquantel, 40 parts~50 parts of powdered beef, 15 parts~25 parts of starch, starch slurry
1 part~10 parts, 1 part~2 parts of dextrin, 0.5 part~1 part of magnesium stearate.
2. pet composite tablet according to claim 1, which is characterized in that the starch slurry be mass fraction 6%~
10% starch slurry.
3. pet composite tablet according to claim 1, which is characterized in that the composite tablet by pressing mass parts below
Meter at being grouped as: 19 parts~20 parts of Pyrantel Pamoate, 9 parts~11 parts of praziquantel, 40 parts~50 parts of powdered beef, starch 15
Part~25 parts, 1 part~10 parts of starch slurry, 1 part~2 parts of dextrin, 0.5 part~1 part of magnesium stearate.
4. pet composite tablet according to claim 1, which is characterized in that the composite tablet by pressing mass parts below
Meter at being grouped as: 20 parts of Pyrantel Pamoate, 10 parts of praziquantel, 40 parts~50 parts of powdered beef, 15 parts~25 parts of starch, form sediment
1 part~10 parts of slurry, 1 part~2 parts of dextrin, 0.5 part~1 part of magnesium stearate.
5. pet composite tablet according to claim 1, which is characterized in that the usage and dosage of the composite tablet is every
0.5 gram~1.0 grams of the pet dosage of 5 kilograms~10 kg body weights.
6. a kind of pet composite tablet preparation method, which is characterized in that the preparation method comprises the following steps:
In parts by mass, by 18 parts~22 parts of Pyrantel Pamoate, 8 parts~13 parts of praziquantel, 40 parts~50 parts of ox
Digested tankage, 15 parts~25 parts of starch mix, and obtain mixture；
1 part~10 parts starch slurries are added in the mixture, softwood is prepared；
0.5 part~1 part of magnesium stearate and 1 part~2 parts dextrin is added in granulation, whole grain, mixes, and tabletting obtains composite tablet.
7. pet according to claim 6 composite tablet preparation method, which is characterized in that the starch slurry is quality point
The starch slurry of number 6%~10%.
8. pet according to claim 6 composite tablet preparation method, which is characterized in that the step for obtaining mixture
Rapid includes in parts by mass, by 19 parts~20 parts of Pyrantel Pamoate, 9 parts~11 parts of praziquantel, 40 parts~50 parts
Powdered beef, 15 parts~25 parts of starch are uniformly mixed so as to obtain mixture.
9. pet according to claim 6 composite tablet preparation method, which is characterized in that the step for obtaining mixture
Rapid includes in parts by mass, by 20 parts of Pyrantel Pamoate, 10 parts of praziquantel, 40 parts~50 parts of powdered beef, 15 parts
~25 parts of starch is uniformly mixed so as to obtain mixture.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910095782.4A CN109846842A (en) | 2019-01-31 | 2019-01-31 | A kind of pet composite tablet and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910095782.4A CN109846842A (en) | 2019-01-31 | 2019-01-31 | A kind of pet composite tablet and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109846842A true CN109846842A (en) | 2019-06-07 |
Family
ID=66897189
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910095782.4A Pending CN109846842A (en) | 2019-01-31 | 2019-01-31 | A kind of pet composite tablet and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109846842A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1099973A (en) * | 1993-09-08 | 1995-03-15 | 四川省医学科学院寄生虫病防治研究所 | Compound vermifuge for animals |
| CN103083344A (en) * | 2011-11-03 | 2013-05-08 | 青岛康地恩药业股份有限公司 | Compound praziquantel parasite repellent tablet for pets and preparation method thereof |
| CN107519169A (en) * | 2017-09-14 | 2017-12-29 | 中国疾病预防控制中心寄生虫病预防控制所 | A kind of composition for driving away echinococcus for canid and preparation method thereof |
-
2019
- 2019-01-31 CN CN201910095782.4A patent/CN109846842A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1099973A (en) * | 1993-09-08 | 1995-03-15 | 四川省医学科学院寄生虫病防治研究所 | Compound vermifuge for animals |
| CN103083344A (en) * | 2011-11-03 | 2013-05-08 | 青岛康地恩药业股份有限公司 | Compound praziquantel parasite repellent tablet for pets and preparation method thereof |
| CN107519169A (en) * | 2017-09-14 | 2017-12-29 | 中国疾病预防控制中心寄生虫病预防控制所 | A kind of composition for driving away echinococcus for canid and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| 刘蜀宝主编: "《药剂学》", 31 July 2007, 河南科学技术出版社 * |
| 管俊昌等主编: "《病原生物学与免疫学》", 31 January 2018, 中国科学技术大学出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU765915B2 (en) | Use of an acrylic type polymer as disintegrating agent | |
| AU2005221659B2 (en) | Bioavailable solid dosage forms of metaxalone | |
| CN103340324B (en) | Goose feed for improving somatic functions of gooses and production method thereof | |
| CN102977208A (en) | Preparation method, application and medicine composition and preparation of specific egg yolk immunoglobulin (IgY) and acinetobacter baumannii, as well as preparation and kit | |
| Karlberg et al. | Effects of synthetic pyroglutamyl-histidyl-proline-amide on serum levels of thyrotrophin, cortisol, growth hormone, insulin and PBI in normal subjects and patients with pituitary and thyroid disorders | |
| CN109846842A (en) | A kind of pet composite tablet and preparation method thereof | |
| Sylvester et al. | Effects of high dietary fat on the growth and development of ovarian-independent carcinogen-induced mammary tumors in rats | |
| DRUCKEK et al. | Thyroiditis as the presenting manifestation of disseminated extrapulmonary Pneumocystis carinii infection | |
| CN105230969A (en) | Compound feed additive for lactating dairy cows and concentrate supplement thereof | |
| Goel et al. | Fabrication and optimization of fast disintegrating tablets employing interpolymeric chitosan-alginate complex and chitin as novel superdisintegrants | |
| Nishikawa et al. | Coexistence of an Autonomously Functioning Thyroid Nodule in a Patient with Graves' Disease An Unusual Presentation of Marine-Lenhart Syndrome | |
| KR20000024012A (en) | chicken feed with bark of lacquer tree | |
| Mai et al. | Palpation thyroiditis causing new-onset atrial fibrillation | |
| Lyons et al. | Thyroid hormone as a prophylactic agent following radical treatment of breast cancer | |
| CN1175899C (en) | Medicine composition and preparation and use thereof | |
| CN105596312A (en) | Dimemorfan phosphate capsule composition and preparing method thereof | |
| CN106822322B (en) | Combined medicine for treating vaginitis and preparation method thereof | |
| CN116440298B (en) | Medicine for diagnosing helicobacter pylori and preparation method thereof | |
| Yeung et al. | The effect of cement and venting design on the retentive strength and marginal adaptation of CeraOne implant prostheses | |
| Xiaofang et al. | Analysis of iodine nutrition and clinical characteristics of thyroid nodule disease in adult population of Guangzhou | |
| CN109432025A (en) | A kind of Losartan Potassium and gliclazide composition and preparation method thereof | |
| CN106606504A (en) | Garden burnet root sapogenin hydroxypropyl [beta]-cyclodextrin clathrate and preparation method and application thereof | |
| Usuki et al. | Hachimijiogan treatment is effective in the management of infertile women with hyperprolactinemia or bromocriptine-resistant hyperprolactinemia | |
| CN106580998B (en) | A kind of pharmaceutical composition for treating renal hypertension | |
| Tajima et al. | Systemic scleroderma and perforating granuloma annulare: differential diagnosis from calcinosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190607 |